Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target

On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative buy rating and C$0.85 12-month price target. This is the first analyst coverage on the name. Stefan Quenneville headlines, “You Cannot Afford to Forget this Company; AI-Powered Test Could Be a Game-Changer in Alzheimer’s Detection.”

Cognetivity Neurosciences is a telehealth company that helps detect the early signs of cognitive decline using artificial intelligence. The company has developed a platform that takes 5 minutes to determine the patient’s cognitive ability, which it then monitors over time.

The cognitive assessment and training market is currently a U$3.2 billion market and is estimates to be growing at a GAGR of 29%. Cognetivity Neurosciences is looking to take market share in two specific categories: primary care settings, “wherein CGN is focused on having clinicians use this as an assessment in the clinic and at-home,” while the other market is a consumer use case.

Echelon believes that in-clinic sales are a U$250 million market while at-home monitoring is a U$1.2 billion market.

They believe that revenue sharing via a 75:25 structure will incentivize clinicians to use their product which will help drive early adoption. Additionally, they believe that the company is potentially well-positioned to secure contracts with public and private payors, “given the increasing recognition of healthcare cost savings attainable through early detection of disease.”

Below you can see Echelon’s revenue break down going into 2026.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Canopy Growth: Cowen, Canaccord, Cormark Raise Price Targets Following Q1 FY2021 Results

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) released its first fiscal quarter 2021 results on...

Wednesday, August 12, 2020, 03:25:16 PM

Equinox Gold: Haywood Slashes Targets After Poor Q2 Performance

Equinox Gold Corp. (TSX: EQX) last week reported its second quarter financial results. The company...

Monday, August 8, 2022, 03:49:00 PM

Karora: Haywood Reiterates Ratings After Three Year Guidance Announcement

On June 28th, Karora Resources Inc. (TSX: KRR) announced its three-year production guidance, whereby they...

Wednesday, June 30, 2021, 04:53:00 PM

CloudMD: Canaccord Reiterates $3.25 Price Target Following Acquisition

This morning, CloudMD Software & Services (TSXV: DOC) announced that they purchased Rx Infinity, an...

Wednesday, January 27, 2021, 04:01:00 PM

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 10:59:00 AM